At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 154 enrolled
Drug / intervention
Peri-capsular Nerve Group (PENG) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PENG Block Versus LP Block for Postoperative Analgesia After Anterior Total Hip
In Brief
A Phase 4 clinical trial evaluating Peri-capsular Nerve Group (PENG) and Lumbar Plexus Block (LPB) for Pain, Postoperative and Hip Pain Chronic. Completed, enrolled 154 participants across 1 site.
Detailed Summary
The purpose of this randomized, double blinded, prospective study is to compare the postoperative analgesia provided by the PENG block to that provided by the LPB for patients undergoing primary anterior approach THA.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative, Hip Pain Chronic
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2023202420252026
First PostedMar 2022
Enrollment StartJun 2022
Primary CompletionJul 2023
TodayJul 2026
First PostedMar 2, 2022
Enrollment StartJun 13, 2022
Primary CompletionJul 20, 2023
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 4.3 years ago
Interventions
Peri-capsular Nerve Group (PENG)drug
PENG block for postoperative pain management
Lumbar Plexus Block (LPB)other
LPB for postoperative pain management